1.
Identification of druggable mutations in Acute Myeloid Leukemia (AML), such as FLT3-ITD, has led to the development of targeted therapies capable of out-performing cytoto [...]
2022 | Abstract |
2.
This capstone examines why Medicaid and CCO funding mechanisms for temporary medical respite housing remain underutilized at hospital discharge for patients experiencing [...]
2026-06-20 | Capstone |